Financial insights of BVS

MyFinsight

For the year ending 2025-12-31, BVS made $568,087K in revenue. $22,732K in net income. Net profit margin of 4.00%.

Income Statement	2025-12-31
Net sales	568,087
Cost of sales (including depreciation and amortization of 41,251, 41,882 and 48,503, respectively)	179,930
Gross profit	388,157
Selling, general and administrative expense	314,026
Research and development expense	12,113
Restructuring costs	2,235
Change in fair value of contingent consideration	0
Depreciation and amortization	5,727
Impairment of assets	0
Loss on disposals	-81
Operating income (loss)	53,975
Interest expense, net	-26,486
Loss on extinguishment	-326
Other expense (income)	-1,454
Other expense	-28,266
Income (loss) before income taxes	25,709
Income tax (benefit) expense, net	-1,565
Net income (loss) from continuing operations	27,274
Loss from discontinued operations, net of tax	0
Net income (loss)	27,274
(income) loss attributable to noncontrolling interest - continuing operations	4,542
Loss attributable to noncontrolling interest - discontinued operations	0
Net income (loss) attributable to bioventus inc	22,732

Basic EPS	0.34
Diluted EPS	0.33
Basic Average Shares	66,622,631
Diluted Average Shares	68,914,895